Aion Therapeutic Inc.

CNSX:AION Stock Report

Market Cap: CA$4.8m

Aion Therapeutic Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

John Simmonds

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

CEO Compensation Analysis

How has John Simmonds's remuneration changed compared to Aion Therapeutic's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-CA$6m

Apr 30 2024n/an/a

-CA$6m

Jan 31 2024n/an/a

-CA$1m

Oct 31 2023n/an/a

-CA$934k

Jul 31 2023n/an/a

-CA$879k

Apr 30 2023n/an/a

-CA$257k

Jan 31 2023n/an/a

-CA$2m

Oct 31 2022n/an/a

-CA$2m

Jul 31 2022n/an/a

-CA$3m

Apr 30 2022n/an/a

-CA$4m

Jan 31 2022n/an/a

-CA$7m

Oct 31 2021n/an/a

-CA$8m

Jul 31 2021n/an/a

-CA$8m

Apr 30 2021n/an/a

-CA$8m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$2m

Jul 31 2020n/an/a

-CA$660k

Apr 30 2020CA$23kCA$23k

-CA$673k

Compensation vs Market: Insufficient data to establish whether John's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.

CEO

John Simmonds (50 yo)

4.9yrs

Tenure

CA$22,500

Compensation

Mr. John Graham Simmonds, Jr., has been the Chief Executive Officer of Gilla Inc. since November 15, 2012. Mr. Simmonds is the Founder of Baymount Incorp., and has been its Chief Executive Officer since Se...

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 18:00
End of Day Share Price 2024/12/23 00:00
Earnings2024/07/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aion Therapeutic Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution